Delivery Order SPE2DB24D1104-SPE2DB25FXXF8

Award Date 2/4/25
Potential Completion Date 2/5/25
Potential Value $31K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of ENBREL 50 MG/ML SURECLICKML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, in the amount of $27,263.59 under a Firm Fixed Price Delivery Order. The contract has an ultimate completion date of February 27, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of ENBREL 50 MG/ML SURECLICKML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $54,124.46 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 22, 2024, with an ultimate completion date of October 23, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop...
This federal contract award is for the supply of ENBREL 50 MG/ML SURECLICKML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $51,905.73 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 15, 2025, with an ultimate completion date of January 16, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which...
The federal contract award is for the delivery of ENBREL 50 MG/ML SURECLICKML to the Defense Logistics Agency (DLA). The $27,536.64 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
The federal contract award details a delivery order valued at $30,354.93 for ENBREL 50 MG/ML SURECLICKML, a pharmaceutical product, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally....
This federal contract award is for the delivery of ENBREL 50 MG/ML SURECLICK medication, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $52,113.13 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on October 22, 2024 with a completion date of October 23, 2024. This delivery order is a part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
The federal contract award is for the delivery of ENBREL 50 MG/ML SURECLICKML pharmaceutical products. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $5,408.94 and is a Firm Fixed Price Delivery Order with a completion date of March 13, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This federal contract award is for the delivery of ENBREL 50 MG/ML SURECLICKML pharmaceutical products to the Defense Logistics Agency (DLA). The $11,133.54 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of April 23, 2025 and is not set aside for any specific business category. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of ENBREL 50 MG/ML SURECLICKML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $4,626.77 firm-fixed-price contract has an ultimate completion date of April 1, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award is for the delivery of ENBREL 50 MG/ML SURECLICKML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $20,111.01, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a ceiling value of $999,999,999...
  • SPE2DB24D1104
    Indefinite Delivery Contract
  • SPE2DB24D1104-SPE2DB25FXXF8
    Delivery Order

The federal contract award is for the delivery of ENBREL 50 MG/ML SURECLICKML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $30,868.43 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 4, 2025, with a completion date of February 5, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract does not have a set-aside designation, indicating open competition. The award supports the DLA's healthcare programs for military personnel, veterans, and other federal beneficiaries by providing essential pharmaceutical products.

Generated 5/21/25, 9:53 AM